Two threshold levels of vitamin D and the prevalence of comorbidities in outpatients of a tertiary hospital.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this observational study publication.

INTRODUCTION: This study evaluated the comorbidities between two values of 25OHD in outpatients of a tertiary hospital.

Who Took Part

By PubMed's age tags, the people studied were adults, middle-aged adults and older adults, both men and women.

This is a cross-sectional study with measures of 25OHD in 1-year period, excluding 25OHD < 20 and > 50 ng/mL, clinical research participants, and liver disease and chronic renal failure patients.

Patients were divided into two groups: group 1 (G1), 25OHD ≥ 20 and < 30 ng/mL; and group 2 (G2), 250HD ≥ 30 and ≤ 50 ng/mL.

How the Study Was Run

Medical records were reviewed for demographic, laboratory, and comorbidity data.

What Was Measured

INTRODUCTION: This study evaluated the comorbidities between two values of 25OHD in outpatients of a tertiary hospital.

PubMed files the paper under topics including Bone Density, Brazil, Comorbidity, Cross-Sectional Studies, Outpatients, Prevalence and Tertiary Care Centers.

The authors tagged it with the keywords Comorbidities, Deficiency, Vitamin D and Vitamin D threshold.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2018 (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.